Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Edmund S. Sabanegh, Jr., MD, is Chairman of the Department of Urology and Professor of Surgery (Urology) at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He serves in a number of areas of leadership at Cleveland Clinic including the Board of Governors, Strategic Advisory Council, Financial Planning Committee and is Vice-Chair of the Glickman Urological & Kidney Institute. He is Director of the Center for Male Fertility at Cleveland Clinic. Dr. Sabanegh earned a Bachelor of Science and Engineering in Chemical Engineering at Princeton University, and he received his medical degree from the University of Virginia College of Medicine in 1985. He performed his urology residency at Wilford Hall Air Force Medical Center in San Antonio, Texas. In 1994, he completed an infertility/microsurgery fellowship at Cleveland Clinic in Cleveland, Ohio. Following that, he returned to San Antonio, Texas, where he served in the United States Air Force until 2006. In 2006, Dr. Sabanegh returned to Cleveland and joined the Department of Urology at Cleveland Clinic. Under his chairmanship, the Department of Urology was rated as the number one urology program in the nation, according to the U.S. News & World Report annual survey.
His surgical interests include microsurgical reconstruction of the male reproductive tract and advanced sperm harvest techniques. His research interests include complex reconstructions for obstruction of the reproductive tract, fertility preservation in cancer patients, varicoceles and environmental influences on fertility.
Dr. Sabanegh has published more than 100 scientific articles and chapters in peer-reviewed journals and has authored a textbook entitled "Male Infertility - Problems and Solutions".
Dr. Sabanegh is board-certified by the American Board of Urology. He is a past Chief Consultant for the Surgeon General of the United States Air Force. He holds active membership in the American Society for Reproductive Medicine, the American Urologic Association and the Society for the Study of Male Reproduction and Urology. He is Assistant Editor for UROLOGY and has served as a reviewer for the Journal of Andrology, Journal of Urology, British Journal of Urology and Fertility and Sterility. He has been recognized with listings in America's Top Doctors (Castle Connolly), "Best Doctors in America" and Best Doctors by Cleveland Magazine.
Male and female fertility (infertility), urologic microsurgery, Klinefelter Syndrome, varicoceles, kidney stones, hormone replacement therapy (HRT), vasectomy, vasectomy reversal
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/2/2013, Dr. Sabanegh has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.